These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12399556)

  • 1. Endocrinology. Divorcing estrogen's bright and dark sides.
    Miller G
    Science; 2002 Oct; 298(5594):723-4. PubMed ID: 12399556
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of bone loss in mice by nongenotropic signaling of sex steroids.
    Kousteni S; Chen JR; Bellido T; Han L; Ali AA; O'Brien CA; Plotkin L; Fu Q; Mancino AT; Wen Y; Vertino AM; Powers CC; Stewart SA; Ebert R; Parfitt AM; Weinstein RS; Jilka RL; Manolagas SC
    Science; 2002 Oct; 298(5594):843-6. PubMed ID: 12399595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coming to grips with bone loss.
    Marx J
    Science; 2004 Sep; 305(5689):1420-2. PubMed ID: 15353792
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts.
    Imai Y; Youn MY; Kondoh S; Nakamura T; Kouzmenko A; Matsumoto T; Takada I; Takaoka K; Kato S
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E31-9. PubMed ID: 19751412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression: Oestrogen receptor hijacked.
    Brosens JJ; Parker MG
    Nature; 2003 May; 423(6939):487-8. PubMed ID: 12774104
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
    Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
    Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene.
    Rosati RL; Da Silva Jardine P; Cameron KO; Thompson DD; Ke HZ; Toler SM; Brown TA; Pan LC; Ebbinghaus CF; Reinhold AR; Elliott NC; Newhouse BN; Tjoa CM; Sweetnam PM; Cole MJ; Arriola MW; Gauthier JW; Crawford DT; Nickerson DF; Pirie CM; Qi H; Simmons HA; Tkalcevic GT
    J Med Chem; 1998 Jul; 41(16):2928-31. PubMed ID: 9685230
    [No Abstract]   [Full Text] [Related]  

  • 8. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.
    Manavathi B; Kumar R
    J Cell Physiol; 2006 Jun; 207(3):594-604. PubMed ID: 16270355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doisynolic acids: potent estrogens with very low affinity for estrogen receptors.
    Meyers CY; Kolb VM; Dandliker WB
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):165-8. PubMed ID: 7058286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen's effects on mitochondrial gene expression: mechanisms and potential contributions to estrogen carcinogenesis.
    Chen JQ; Yager JD
    Ann N Y Acad Sci; 2004 Dec; 1028():258-72. PubMed ID: 15650251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensing estrogen's many pathways.
    Weatherman RV
    ACS Chem Biol; 2008 Jun; 3(6):338-40. PubMed ID: 18570353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of phenolic antidiarrheic ingredients prevents ovariectomy-induced bone loss.
    Moriguchi N; Hinoi E; Takarada T; Matsushima N; Uno K; Yoneda Y
    Biochem Pharmacol; 2007 Feb; 73(3):385-93. PubMed ID: 17078932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.
    Nakamura T; Imai Y; Matsumoto T; Sato S; Takeuchi K; Igarashi K; Harada Y; Azuma Y; Krust A; Yamamoto Y; Nishina H; Takeda S; Takayanagi H; Metzger D; Kanno J; Takaoka K; Martin TJ; Chambon P; Kato S
    Cell; 2007 Sep; 130(5):811-23. PubMed ID: 17803905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency.
    Schiltz C; Marty C; de Vernejoul MC; Geoffroy V
    J Cell Biochem; 2008 Aug; 104(5):1803-17. PubMed ID: 18384129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor-beta modulates synthesis of bone matrix proteins in human osteoblast-like MG63 cells.
    Cao L; Bu R; Oakley JI; Kalla SE; Blair HC
    J Cell Biochem; 2003 May; 89(1):152-64. PubMed ID: 12682916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ostreae Testa prevent ovariectomy-induced bone loss in mice by osteoblast activations.
    Han SY; Lee JR; Kwon YK; Jo MJ; Park SJ; Kim SC; Lee HS; Ku SK
    J Ethnopharmacol; 2007 Dec; 114(3):400-5. PubMed ID: 17905549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug's link to genes reveals estrogen's many sides.
    Pennisi E
    Science; 1996 Aug; 273(5279):1171. PubMed ID: 8787121
    [No Abstract]   [Full Text] [Related]  

  • 19. Estren is a selective estrogen receptor modulator with transcriptional activity.
    Movérare S; Dahllund J; Andersson N; Islander U; Carlsten H; Gustafsson JA; Nilsson S; Ohlsson C
    Mol Pharmacol; 2003 Dec; 64(6):1428-33. PubMed ID: 14645673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bovine lactoferrin improves bone status of ovariectomized mice.
    Blais A; Malet A; Mikogami T; Martin-Rouas C; Tomé D
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1281-8. PubMed ID: 19336659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.